FDA and representatives of the generic drug industry meet bi-annually to discuss current and emerging regulatory science challenges and concerns. Minutes from these meetings are posted on this page.

FDA - Industry Regulatory Science Work Group Meeting FY 2023

FDA - Industry Regulatory Science Work Group Meeting FY 2022

FDA - Industry Regulatory Science Work Group Meeting FY 2021

FDA - Industry Regulatory Science Work Group Meeting FY 2020

FDA – Industry Regulatory Science Work Group Meetings FY 2019

FDA - Industry Regulatory Science Work Group Meetings FY 2018